{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:35:35Z","timestamp":1793147735522,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41397-026-00433-1","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:51:34Z","timestamp":1791222694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bridging the pharmacogenomics gap: a survey of healthcare workers in South-Western Nigeria"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3671-9717","authenticated-orcid":false,"given":"Ochuko M.","family":"Orherhe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omolabake F.","family":"Ayodele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah O.","family":"Omojuyigbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayodapo O.","family":"Jegede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olumide A.","family":"Alade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kikelomo","family":"Oladimeji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwatimilehin S.","family":"Ogunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6801-6207","authenticated-orcid":false,"given":"Promise U.","family":"Okereke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwafemi O.","family":"Agboola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1775-0664","authenticated-orcid":false,"given":"Moteehat O.","family":"Olu-Lawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olusanya","family":"Aluko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babatunde A.","family":"Adeagbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8295-7150","authenticated-orcid":false,"given":"Oluseye O.","family":"Bolaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"433_CR1","doi-asserted-by":"publisher","unstructured":"Qahwaji R, Ashankyty I, Sannan NS, Hazzazi MS, Basabrain AA, Mobashir M Pharmacogenomics: a genetic approach to drug development and therapy. Pharmaceuticals (Basel). 2024;17. https:\/\/doi.org\/10.3390\/ph17070940","DOI":"10.3390\/ph17070940"},{"key":"433_CR2","doi-asserted-by":"publisher","first-page":"e42240","DOI":"10.1097\/MD.0000000000042240","volume":"104","author":"MS Alharthi","year":"2025","unstructured":"Alharthi MS. How equipped are pharmacists for pharmacogenomics? A cross-sectional study on knowledge, attitudes, and implementation practices in Saudi Arabia. Medicine (Baltimore). 2025;104:e42240 https:\/\/doi.org\/10.1097\/MD.0000000000042240","journal-title":"Medicine (Baltimore)"},{"key":"433_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3390\/genes11060679","volume":"11","author":"E Cecchin","year":"2020","unstructured":"Cecchin E, Stocco G. Pharmacogenomics and personalized medicine. Genes. 2020;11:679 https:\/\/doi.org\/10.3390\/genes11060679","journal-title":"Genes"},{"key":"433_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature15817","volume":"526","author":"MV Relling","year":"2015","unstructured":"Relling MV, Evans WE. Pharmacogenomics in the clinic. Nature. 2015;526:343\u201350.","journal-title":"Nature"},{"key":"433_CR5","unstructured":"Centers for Disease Control and Prevention. Pharmacogenomics Genomics and Your Health. 2024. https:\/\/www.cdc.gov\/genomics-and-health\/pharmacogenomics\/index.html. Accessed 3 Dec 2025."},{"key":"433_CR6","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.2217\/pgs.12.139","volume":"13","author":"M Moen","year":"2012","unstructured":"Moen M, Lamba J. Assessment of healthcare students\u2019 views on pharmacogenomics at the University of Minnesota. Pharmacogenomics. 2012;13:1537\u201345.","journal-title":"Pharmacogenomics"},{"key":"433_CR7","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3390\/genes11111337","volume":"11","author":"V Rollinson","year":"2020","unstructured":"Rollinson V, Turner R, Pirmohamed M. Pharmacogenomics for primary care: an overview. Genes. 2020;11:1337 https:\/\/doi.org\/10.3390\/genes11111337","journal-title":"Genes"},{"key":"433_CR8","unstructured":"National Human Genome Research Institute. Human Genome Project fact sheet. 2024. https:\/\/www.genome.gov\/about-genomics\/educational-resources\/fact-sheets\/human-genome-project. Accessed 3 Dec, 2025"},{"key":"433_CR9","unstructured":"National Human Genome Research Institute. Telomere-to-Telomere Consortium. 2023. https:\/\/www.genome.gov\/about-genomics\/telomere-to-telomere.Accessed 3 Dec, 2025"},{"key":"433_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3390\/jpm11030179","volume":"11","author":"JA Kim","year":"2021","unstructured":"Kim JA, Ceccarelli R, Lu CY. Pharmacogenomic biomarkers in US FDA-approved drug labels (2000-2020). J Pers Med. 2021;11:179 https:\/\/doi.org\/10.3390\/jpm11030179","journal-title":"J Pers Med"},{"key":"433_CR11","unstructured":"U.S. Food and Drug Administration. Table of pharmacogenomic biomarkers in drug labeling. 2024. https:\/\/www.fda.gov\/drugs\/science-and-research-drugs\/table-pharmacogenomic-biomarkers-drug-labeling. Accessed 3 Dec, 2025"},{"key":"433_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.21037\/jlpm-24-36","volume":"10","author":"AG Kanegusuku","year":"2025","unstructured":"Kanegusuku AG, Chan CW, Thoburn CA, van Wijk XMR, Tang NY. Challenges and considerations in implementing clinical pharmacogenomics. J Lab Precis Med. 2025;10:2.","journal-title":"J Lab Precis Med"},{"key":"433_CR13","first-page":"1","volume":"311","author":"D Connelly","year":"2023","unstructured":"Connelly D. Pharmacogenomic testing pilot to start in general practice from June 2023. Pharm J. 2023;311:1\u20134.","journal-title":"Pharm J"},{"key":"433_CR14","doi-asserted-by":"publisher","first-page":"R164","DOI":"10.1093\/hmg\/ddab180","volume":"30","author":"M Kamp","year":"2021","unstructured":"Kamp M, Krause A, Ramsay M. Has translational genomics come of age in Africa? Hum Mol Genet. 2021;30:R164\u2013R173. https:\/\/doi.org\/10.1093\/hmg\/ddab180","journal-title":"Hum Mol Genet"},{"key":"433_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s43856-025-00955-y","volume":"5","author":"MZ Alimohamed","year":"2025","unstructured":"Alimohamed MZ, Obeng GD, Csanadi M, Masimirembwa C, Dandara C. Implementing health economics for pharmacogenomics research translation in Africa. Commun Med (Lond). 2025;5:241 https:\/\/doi.org\/10.1038\/s43856-025-00955-y","journal-title":"Commun Med (Lond)"},{"key":"433_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.12688\/aasopenres.12965.1","volume":"2","author":"C Dandara","year":"2019","unstructured":"Dandara C, Masimirembwa C, Haffani YZ, Ogutu B, Mabuka J, Aklillu E, et al. African Pharmacogenomics Consortium: consolidating pharmacogenomics knowledge, capacity development and translation in Africa. AAS Open Res. 2019;2:19 https:\/\/doi.org\/10.12688\/aasopenres.12965.1","journal-title":"AAS Open Res"},{"key":"433_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-022-00435-x","volume":"15","author":"U Abubakar","year":"2022","unstructured":"Abubakar U, Subramaniam L, Ayinla A, Ambali MN, Mohamed Noor DA, Daud NAA, et al. Knowledge, attitude and perception of community pharmacists towards pharmacogenomics services in northern Nigeria: a cross-sectional study. J Pharm Policy Pract. 2022;15:39 https:\/\/doi.org\/10.1186\/s40545-022-00435-x","journal-title":"J Pharm Policy Pract"},{"key":"433_CR18","doi-asserted-by":"publisher","first-page":"e1844","DOI":"10.1002\/hsr2.1844","volume":"7","author":"A Wondrasek","year":"2024","unstructured":"Wondrasek A, Fryza A, Aziz MA, Leong C, Kowalec K, Maruf AAL. Knowledge, perceptions, and attitudes toward pharmacogenomics among pharmacists and pharmacy students: a systematic review. Health Sci Rep. 2024;7:e1844 https:\/\/doi.org\/10.1002\/hsr2.1844","journal-title":"Health Sci Rep"},{"key":"433_CR19","doi-asserted-by":"publisher","DOI":"10.1017\/gheg.2016.21","volume":"2","author":"KL Mpye","year":"2017","unstructured":"Mpye KL, Matimba A, Dzobo K, Chirikure S, Wonkam A, Dandara C. Disease burden and the role of pharmacogenomics in African populations. Glob Health Epidemiol Genom. 2017;2:e1 https:\/\/doi.org\/10.1017\/gheg.2016.21","journal-title":"Glob Health Epidemiol Genom"},{"key":"433_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/20523211.2024.2429785","volume":"17","author":"SJ Alnaimi","year":"2024","unstructured":"Alnaimi SJ, Ajaj F, Awaisu A, Alhathal T, Mohammed S, Alhail M. Assessment of knowledge, perceptions, and readiness of healthcare professionals towards clinical pharmacogenomics implementation in Qatar: a mixed-method study. J Pharm Policy Pract. 2024;17:2429785 https:\/\/doi.org\/10.1080\/20523211.2024.2429785","journal-title":"J Pharm Policy Pract"},{"key":"433_CR21","doi-asserted-by":"publisher","DOI":"10.1177\/11786302241250211","volume":"18","author":"RO Adesola","year":"2024","unstructured":"Adesola RO, Opuni E, Idris I, Okesanya OJ, Igwe O, Abdulazeez MD, et al. Navigating Nigeria\u2019s health landscape: population growth and its health implications. Environ Health Insights. 2024;18:11786302241250211 https:\/\/doi.org\/10.1177\/11786302241250211","journal-title":"Environ Health Insights"},{"key":"433_CR22","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2217\/pgs-2019-0046","volume":"20","author":"OO Bolaji","year":"2019","unstructured":"Bolaji OO, Adehin A, Adeagbo BA. Pharmacogenomics in the Nigerian population: the past, the present and the future. Pharmacogenomics. 2019;20:915\u201326.","journal-title":"Pharmacogenomics"},{"key":"433_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.dmpk.2016.09.001","volume":"32","author":"A Adehin","year":"2017","unstructured":"Adehin A, Bolaji OO, Kennedy MA. Polymorphisms in CYP2C8 and CYP3A5 genes in the Nigerian population. Drug Metab Pharmacokinet. 2017;32:189\u201391.","journal-title":"Drug Metab Pharmacokinet"},{"key":"433_CR24","first-page":"97","volume":"22","author":"P Madadi","year":"2011","unstructured":"Madadi P, Enato EFO, Babatunde EO. Perceptions of health care professionals towards pharmacogenomics in Nigeria: preliminary results. West Afr J Pharm. 2011;22:97\u2013101.","journal-title":"West Afr J Pharm"},{"key":"433_CR25","doi-asserted-by":"publisher","first-page":"718","DOI":"10.46542\/pe.2024.241.718729","volume":"24","author":"OA Ade-adekunle","year":"2024","unstructured":"Ade-adekunle OA, Dada PA, Adekunle FO, Abiola AE, Babalola DG, Soderu IJ, et al. Assessment of healthcare students\u2019 knowledge, attitudes, and perceptions towards pharmacogenomics at Olabisi Onabanjo University, Nigeria. Pharm Educ. 2024;24:718\u201329.","journal-title":"Pharm Educ"},{"key":"433_CR26","unstructured":"Japan International Cooperation Agency. Data collection survey on the health system in Nigeria: final report. WHO; 2021. https:\/\/openjicareport.jica.go.jp\/pdf\/1000045944.pdf. Accessed 3 Dec, 2025"},{"key":"433_CR27","unstructured":"Lawal N. Top 10 States with Highest Number of Medical Doctors in Nigeria. 2021. Available from: https:\/\/www.legit.ng\/1432792-list-top-10-states-highest-number-medical-doctors.html. Accessed 3 May 2024."},{"key":"433_CR28","volume-title":"Statistics: An Introductory Analysis","author":"T Yamane","year":"1967","unstructured":"Yamane T. Statistics: An Introductory Analysis. 2nd ed. New York: Harper & Row; 1967.","edition":"2nd ed."},{"key":"433_CR29","doi-asserted-by":"publisher","first-page":"e1179","DOI":"10.1002\/hpm.2603","volume":"33","author":"OA Makinde","year":"2018","unstructured":"Makinde OA, Sule A, Ayankogbe O, Boone D. Distribution of health facilities in Nigeria: implications and options for universal health coverage. Int J Health Plann Manage. 2018;33:e1179\u2013e1192.","journal-title":"Int J Health Plann Manage"},{"key":"433_CR30","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/cts.13672","volume":"16","author":"CX Lim","year":"2023","unstructured":"Lim CX, Bozkurt A, Chen ZY, Hird A, Wickens J, Lazarakis S, et al. Healthcare professionals\u2019 and consumers\u2019 Knowledge, attitudes, perspectives, and education needs in oncology pharmacogenomics: a systematic review. Clin Transl Sci. 2023;16:2467\u201382.","journal-title":"Clin Transl Sci"},{"key":"433_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/jpm10030134","volume":"10","author":"AT Rahma","year":"2020","unstructured":"Rahma AT, Elbarazi I, Ali BR, Patrinos GP, Ahmed LA, Al Maskari F. Genomics and pharmacogenomics knowledge, attitude and practice of pharmacists in the United Arab Emirates. J Pers Med. 2020;10:134 https:\/\/doi.org\/10.3390\/jpm10030134","journal-title":"J Pers Med"},{"key":"433_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4314\/gmj.v49i1.9","volume":"49","author":"W Kudzi","year":"2015","unstructured":"Kudzi W, Addy BS, Dzudzor B. Knowledge of pharmacogenetics among healthcare professionals and faculty members in Ghana. Ghana Med J. 2015;49:50\u201356.","journal-title":"Ghana Med J"},{"key":"433_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.551522","volume":"11","author":"W Mufwambi","year":"2021","unstructured":"Mufwambi W, Stingl J, Masimirembwa C, Manasa J, Nhachi C, Stadler N, et al. Healthcare professionals\u2019 knowledge of pharmacogenetics in Zambia. Front Pharmacol. 2021;11:551522 https:\/\/doi.org\/10.3389\/fphar.2020.551522","journal-title":"Front Pharmacol"},{"key":"433_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2217\/pme-2019-0163","volume":"17","author":"M Nagy","year":"2020","unstructured":"Nagy M, Lynch M, Kamal S, Mohamed S, Hadad A, Abouelnaga S, et al. Knowledge, attitudes and challenges of clinical pharmacogenetic testing in Egypt. Per Med. 2020;17:251\u201360.","journal-title":"Per Med"},{"key":"433_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.31436\/imjm.v13i1.491","volume":"13","author":"Z Bannur","year":"2014","unstructured":"Bannur Z, Bahaman S, Salleh MZ, Kek TL. Pharmacogenomics-based practice in Malaysia. Int Med J Malays. 2014;13:41\u201350. https:\/\/doi.org\/10.31436\/imjm.v13i1.491","journal-title":"Int Med J Malays"},{"key":"433_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09171-6","volume":"22","author":"KS Lau-Min","year":"2022","unstructured":"Lau-Min KS, Varughese LA, Nelson MN, Cambareri C, Reddy NJ, Oyer RA, et al. Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation. BMC Cancer. 2022;22:47 https:\/\/doi.org\/10.1186\/s12885-022-09171-6","journal-title":"BMC Cancer"},{"key":"433_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/FPC.0000000000000362","volume":"29","author":"BA Borden","year":"2019","unstructured":"Borden BA, Galecki P, Wellmann R, Danahey K, Lee SM, Patrick-Miller L, et al. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study. Pharmacogenet Genomics. 2019;29:31\u201338.","journal-title":"Pharmacogenet Genomics"},{"key":"433_CR38","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1093\/ajhp\/zxz060","volume":"76","author":"S Coriolan","year":"2019","unstructured":"Coriolan S, Arikawe N, Moscati A, Zhou L, Dym S, Donmez S, et al. Pharmacy students\u2019 attitudes toward pharmacogenomics education. Am J Health Syst Pharm. 2019;76:836\u201345.","journal-title":"Am J Health Syst Pharm"},{"key":"433_CR39","first-page":"279","volume":"10","author":"OA Abdela","year":"2017","unstructured":"Abdela OA, Bhagavathula AS, Gebreyohannes EA, Tegegn HG. Ethiopian healthcare professionals\u2019 knowledge and attitudes toward pharmacogenomics. Pharmacogenomics Pers Med. 2017;10:279\u201385.","journal-title":"Pharmacogenomics Pers Med"},{"key":"433_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.46542\/pe.2024.249.1523","volume":"24","author":"N Handayani","year":"2024","unstructured":"Handayani N, Niruri R, Farida Y, Ikakusumawati ND, Sholihah I, Prihapsara F. Interprofessional approach in pharmacogenomics: a systematic review. Pharm Educ. 2024;24:15\u201323.","journal-title":"Pharm Educ"},{"key":"433_CR41","unstructured":"HOME - Federal Ministry of Health and Social Welfare. https:\/\/health.gov.ng\/. Accessed 3 Dec, 2025"},{"key":"433_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/pharmacy5030036","volume":"5","author":"N Muzoriana","year":"2017","unstructured":"Muzoriana N, Gavi S, Nembaware V, Dhoro M, Matimba A. Knowledge, Attitude, and Perceptions of Pharmacists and Pharmacy Students towards Pharmacogenomics in Zimbabwe. Pharmacy (Basel). 2017;5:36 https:\/\/doi.org\/10.3390\/pharmacy5030036","journal-title":"Pharmacy (Basel)"},{"key":"433_CR43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5688\/ajpe75351","volume":"75","author":"KB McCullough","year":"2011","unstructured":"McCullough KB, Formea CM, Berg KD, Burzynski JA, Cunningham JL, Ou NN, et al. Assessment of the pharmacogenomics educational needs of pharmacists. Am J Pharm Educ. 2011;75:51 https:\/\/doi.org\/10.5688\/ajpe75351","journal-title":"Am J Pharm Educ"},{"key":"433_CR44","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/ajhp\/zxab339","volume":"79","author":"CE Haidar","year":"2022","unstructured":"Haidar CE, Petry N, Oxencis C, Douglas JS, Hoffman JM. ASHP statement on the pharmacist\u2019s role in clinical pharmacogenomics. Am J Health Syst Pharm. 2022;79:704\u20137.","journal-title":"Am J Health Syst Pharm"},{"key":"433_CR45","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/s41436-021-01186-x","volume":"23","author":"NJ Keeling","year":"2021","unstructured":"Keeling NJ, Dunn TJ, Bentley JP, Ramachandran S, Hoffman JM, Rosenthal M. Approaches to assessing the provider experience with clinical pharmacogenomic information: a scoping review. Genet Med. 2021;23:1589\u2013603.","journal-title":"Genet Med"},{"key":"433_CR46","first-page":"113","volume":"7","author":"MJ Kennedy","year":"2018","unstructured":"Kennedy MJ. Personalized medicines\u2014are pharmacists ready for the challenge? Integr Pharm Res Pract. 2018;7:113\u201323.","journal-title":"Integr Pharm Res Pract"},{"key":"433_CR47","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1331\/JAPhA.2011.11543","volume":"51","author":"SM Reiss","year":"2011","unstructured":"Reiss SM, American Pharmacists Association. Integrating pharmacogenomics into pharmacy practice via medication therapy management. J Am Pharm Assoc (2003). 2011;51:e64\u2013e74.","journal-title":"J Am Pharm Assoc (2003)"},{"key":"433_CR48","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/jac5.1175","volume":"3","author":"S Weinstein","year":"2020","unstructured":"Weinstein S, Carroll JC, Jukic S, McGivney MS, Klatt P. Perspectives of a pharmacist-run pharmacogenomic service for depression in interdisciplinary family medicine practices. J Am Coll Clin Pharm. 2020;3:417\u201324.","journal-title":"J Am Coll Clin Pharm"},{"key":"433_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12912-025-02847-x","volume":"24","author":"AH Moloro","year":"2025","unstructured":"Moloro AH, Sabo KG, Lahole BK, Wengoro BF, Mare KU. Prevalence of interprofessional collaboration towards patient care and associated factors among nurses and physician in Ethiopia: a systematic review and meta-analysis. BMC Nurs. 2025;24:210 https:\/\/doi.org\/10.1186\/s12912-025-02847-x","journal-title":"BMC Nurs"},{"key":"433_CR50","doi-asserted-by":"publisher","first-page":"841135","DOI":"10.3389\/fmed.2022.876715","volume":"9","author":"R Samuriwo","year":"2022","unstructured":"Samuriwo R. Interprofessional collaboration\u2014time for a new theory of action? Front Med (Lausanne). 2022;9:841135 https:\/\/doi.org\/10.3389\/fmed.2022.876715","journal-title":"Front Med (Lausanne)"},{"key":"433_CR51","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2217\/pgs-2023-0179","volume":"24","author":"SA Shue","year":"2023","unstructured":"Shue SA, Rowe E, Bell LA, Damush T, DeLong A, Gowan T, et al. Pharmacogenomics implementation across multiple clinic settings: a qualitative evaluation. Pharmacogenomics. 2023;24:881\u201393.","journal-title":"Pharmacogenomics"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00433-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00433-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00433-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:21:58Z","timestamp":1793146918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00433-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["433"],"URL":"https:\/\/doi.org\/10.1038\/s41397-026-00433-1","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"39"}}